
Supercomputers Zeroing In on New Alzheimer’s Drugs
Plaque is the prime suspect behind Alzheimer’s. Amyloid-beta combines to form oligomers, which make up the plaque that clogs up the Alzheimer’s brain. Though we
Plaque is the prime suspect behind Alzheimer’s. Amyloid-beta combines to form oligomers, which make up the plaque that clogs up the Alzheimer’s brain. Though we
VIDEO: How do we tackle Alzheimer’s and dementia? How will patients, their caregivers and health care systems cope? Global entities, such as the OECD, are
The future is looking good for drugs designed to combat Alzheimer’s disease. Learn about new knowledge that holds the potential to keep Alzheimer’s in check.
VIDEO: Professional athlete Patrick Grange died with CTE dementia. Learn the connection between CTE dementia and activities that are hard on the head.
VIDEO & IN-DEPTH ARTICLE Good news from England: “Dementia rates fall as public health improves.” Learn about Cambridge University’s authoritative study based on 20 years
VIDEO Dr. Rudy Tanzi, Harvard’s top Alzheimer’s expert, explores where we are and what we can do about Alzheimer’s.
A proven approach to slow the aging process and associated diseases is dietary restriction. New research helps explain the action of a drug that appears
RESEARCH VIDEO See how the U.S. government’s NIH sets the pace of America’s dementia research. Learn about their strategies, agendas and the initiatives they empower.
News on bexarotene demands explaining. In the Alzheimer’s lab, this FDA-approved anti-cancer drug improves memory. Since that is what matters to people, funding is pouring
A University of Florida experiment is on its way to the International Space Station. In the weightlessness of space, it will allow scientists to control the
CUTTING-EDGE VIDEO + ARTICLE: See Dr. Anthony Fitzpatrick use world-class cryo-electron microscopes to reveal molecular secrets leading to a cure for Alzheimer’s.
UPLIFTING VIDEO: Peter Berry & his Alzheimer’s are cycling 350 miles to show it’s still possible to live well with dementia.
Participants in a new study had inherited genetic variants that lead to early-onset Alzheimer’s. Among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.